2m 2m 2m 2m 2m 2m 2m
COMPASS THERAPTC (CMPX)
NASDAQ
$2.38-$0.02 (-0.83%)
Price as of Aug 21, 2026 7:45 PM EDT- $432.2MMarket Cap
- -20.53%1-Year Change
- BiotechnologyIndustry
COMPASS THERAPTC (CMPX)
$2.38-$0.02 (-0.83%)
CMPX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.40 | ||
Change | +$0.04 (+1.69%) | ||
Open | $2.39 | ||
High | $2.45 | ||
Low | $2.33 | ||
Previous Close | $2.36 | ||
Volume | 2,032,331 | ||
30-Day Average Volume | 3,250,799 | ||
1-Week Change | 6.67% | ||
1-Month Change | 14.29% | ||
1-Year Change | -20.53% | ||
3-Year Change | 1.69% | ||
5-Year Change | -71.29% | ||
Fundamentals | |||
Shares Outstanding | 180.1M | ||
Total Assets | $190.2M | ||
Market Cap | $432.2M | ||
Enterprise Value | $396.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$25.2M | ||
Free Cash Flow | -$14.9M | ||
EBIT | -$25.2M | ||
EBITDA | -$25.1M | ||
Net Working Capital | $164.8M | ||
EPS | -$0.13 | ||
Enterprise Value/EBITDA | -16 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -18 | ||
PEG | 1 | ||
Price/Free Cash Flow | -29 | ||
Price/Operating Cash Flow | -29 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue